[18F]fluorodeoxyglucose

DIAGNOSTIC_TEST2 trials

Sponsors

Vanderbilt-Ingram Cancer Center, Pentixapharm AG

Conditions

Marginal Zone LymphomaRecurrent MelanomaStage IIIA MelanomaStage IIIB MelanomaStage IIIC MelanomaStage IV Melanoma

Phase 3

[68Ga]Ga-PentixaFor-PET Imaging for Staging of Marginal Zone Lymphoma

TerminatedNCT06125028

Pentixapharm AGMarginal Zone Lymphoma

Start: 2024-05-20End: 2025-07-18Updated: 2025-09-05

Unknown Phase

FDG-PET in Advanced Melanoma

TerminatedNCT02236546

Vanderbilt-Ingram Cancer CenterRecurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma +2

Start: 2012-05-31End: 2015-11-30Updated: 2017-04-13